CAPHRA urges THR evidence review before COP10

Dec.12.2022
CAPHRA urges THR evidence review before COP10
CAPHRA urges tobacco control representatives to review evidence supporting harm reduction methods before COP10.

The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has written letters to the heads of various tobacco-control framework convention delegations urging them to review evidence supporting tobacco harm reduction (THR) methods before COP10.


As governments from around the world send delegates to COP10 in November 2023, CAPHRA is eager to provide comprehensive reference materials to leaders for their planning, submission writing, and review processes.


The 10th Conference of Parties (COP10) will be held in Panama and will be hosted by the World Health Organization's Framework Convention on Tobacco Control.


We, on behalf of the 4 million users in the Asia-Pacific region who currently utilize safer nicotine products, are taking this action. As you may be aware, our region is particularly vulnerable to the harm and deaths caused by combustible and unsafe oral tobacco.


Representatives from CAPHRA have reminded healthcare leaders that the FCTC has the authority to make harm reduction a core tobacco control policy.


For decades, it has been widely accepted that tar and carcinogenic substances found in tobacco smoke are responsible for smoking-related deaths and illnesses, rather than nicotine. Studies have shown that while nicotine can be mildly addictive, similar to caffeine, it is not a health concern, according to the authors.


The letter also calls on representatives to condemn the policy of holding the COP10 conference of the FCTC behind closed doors.


Representatives attending COP10 are expected to represent the rights and wishes of their citizens, whose taxes are funding their attendance. Citizens expect their representatives to speak on their behalf, recognize the scientific support for reducing harm through ENDS, and uphold democratic principles, the letter stated.


CAPHRA representatives are calling on countries to consider consumers' right to make choices that can help them avoid negative health outcomes when submitting their COP10 statements. It is crucial that smokers have access to nicotine products with less harmful effects as alternatives to smoking.


At the fifth Asia Harm Reduction Forum, CAPHRA's executive coordinator Nancy Loucas presented a recently released white paper titled "Disrupting Public Health: A Consumer Perspective," which is based on evidence.


2FIRSTS will continue to cover this topic and provide updates on our mobile application, '2FIRSTSAPP.' Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Ukraine intercepts approximately $40,000 worth of smuggled goods, including a large amount of Elfbar e-cigarettes
Ukraine intercepts approximately $40,000 worth of smuggled goods, including a large amount of Elfbar e-cigarettes
An e-cigarette smuggling operation was uncovered in the Lviv region of Ukraine, resulting in the seizure of 7,500 Elfbar e-cigarettes, valued at over 1.8 million hryvnia (approximately $40,000). The case is under investigation under Ukrainian criminal law.
Sep.23 by 2FIRSTS.ai
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Releases 2025 Financial Results: Revenue of $127.5 Million, Net Loss Widens to $39.2 Million
Ispire Technology Inc. (NASDAQ: ISPR) announced its financial results for the fiscal year ending June 30, 2025, on September 16, 2025. The report showed that the company's operating revenue was $127.5 million, down from $151.9 million in the previous fiscal year. Gross profit decreased from $29.8 million to $22.6 million, with gross profit margin falling from 19.6% to 17.8%. Net loss widened from $14.8 million to $39.2 million.
Sep.17 by 2FIRSTS.ai
US FDA releases MRTP renewal application materials for IQOS heated tobacco product and will hold an expert meeting in October
US FDA releases MRTP renewal application materials for IQOS heated tobacco product and will hold an expert meeting in October
New materials related to Philip Morris Products' MRTP renewal application have been submitted to the FDA for review.
Sep.26 by 2FIRSTS.ai
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
BAT’s VELO has released a McLaren F1 co-branded, track-themed limited-edition pack in McLaren’s orange-black livery. Pricing is about $4.60 per can in the U.S. versus ~$7.40 in the EU/UK. The collaboration extends BAT’s partnership with McLaren dating back to 2019.
Oct.11 by 2FIRSTS.ai
Indonesia’s Finance Minister: No Tobacco Excise Hike in 2026; Focus Shifts to Combating Illicit Cigarettes
Indonesia’s Finance Minister: No Tobacco Excise Hike in 2026; Focus Shifts to Combating Illicit Cigarettes
Indonesia’s finance minister announced that tobacco excise rates will be kept unchanged in 2026 to avoid layoffs and protect industry employment. The government says it will pivot to cleaning up the illicit cigarette market, noting that while tax hikes can curb smoking, they have also pushed consumers toward cheaper brands or smuggled products, hurting compliant businesses and tax revenues.
Sep.28
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
In Sept 2025, the US FDA launched a nicotine pouch PMTA pilot to boost review efficiency, streamline processes and uphold strict scientific standards. Based on the "tobacco product health risk continuum" concept, it shortens cycles by focusing on key product factors and enhancing real-time communication with applicants. The FDA also urges child-resistant packaging to tackle kids’ accidental exposure, emphasizes scientific review for new tobacco products, and has approved 20 nicotine pouches so f
Sep.19 by 2FIRSTS.ai